Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.82 USD | -4.01% | -14.68% | -10.32% |
Apr. 16 | Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration | MT |
Apr. 16 | Transcript : Precision BioSciences, Inc. - Special Call |
Business Summary
Number of employees: 109
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Editing
100.0
%
| 25 | 100.0 % | 49 | 100.0 % | +94.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 25 | 100.0 % | 49 | 100.0 % | +94.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 46 | 21-10-14 |
Jeff Smith
FOU | Founder | - | 06-01-25 |
John Kelly
DFI | Director of Finance/CFO | 57 | 20-10-13 |
Sinu Bhandaru
COO | Chief Operating Officer | - | 17-07-31 |
Alan List
CTO | Chief Tech/Sci/R&D Officer | 69 | 21-04-25 |
Mei Burris
AUD | Comptroller/Controller/Auditor | - | 19-01-31 |
Juli Blanche
HRO | Human Resources Officer | - | 22-05-22 |
Cindy Atwell
PRN | Corporate Officer/Principal | - | 18-12-31 |
Dario Scimeca
LAW | General Counsel | 49 | 19-06-11 |
Neil Leatherbury
PRN | Corporate Officer/Principal | - | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Buehler
CHM | Chairman | 66 | 19-11-07 |
Geno Germano
BRD | Director/Board Member | 63 | 20-03-09 |
Director/Board Member | 75 | 21-11-05 | |
Melinda Brown
BRD | Director/Board Member | - | 22-05-30 |
Michael Amoroso
CEO | Chief Executive Officer | 46 | 21-10-14 |
Stanley Frankel
BRD | Director/Board Member | 65 | 21-04-11 |
Shari Lisa Piré
BRD | Director/Board Member | 59 | 21-11-05 |
Company contact information
Precision BioSciences, Inc.
Dibrell Building 302 East Pettigrew Street
27701, Durham
+919 314 5512
http://www.precisionbiosciences.comSector
EPS Revisions
- Stock Market
- Equities
- DTIL Stock
- Company Precision BioSciences, Inc.